Catalyst Wire Dossier Catalyst Wire Dossier

Autologous adipose-derived mesenchymal stem cells (AMSC)

adipose-derived mesenchymal stem cells · Mayo Clinic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous adipose-derived mesenchymal stem cells (AMSC), covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure [Phase 1]

See pricing